---
title: "Prednisolone - Sarcoidosis"
sidebar: mydoc_sidebar
permalink: db00860-mesh-d012507-1.html
toc: false 
---


Path ID: `DB00860_MESH_D012507_1`
{% include image.html url="images/db00860-mesh-d012507-1.png" file="db00860-mesh-d012507-1.png" alt="db00860-mesh-d012507-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D011239 | prednisolone | Drug |
| UniProt:P04150 | Glucocorticoid receptor | Protein |
| UniProt:P04083 | lipocortins | Protein |
| UniProt:P47712 | phospholipase a2 | Protein |
| GO:0006954 | Inflammation signaling | BiologicalProcess |
| MESH:D012507 | Sarcoidosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Prednisolone | INCREASES ACTIVITY OF | Glucocorticoid Receptor |
| Glucocorticoid Receptor | INCREASES ABUNDANCE OF | Lipocortins |
| Lipocortins | DECREASES ABUNDANCE OF | Phospholipase A2 |
| Phospholipase A2 | PARTICIPATES IN | Inflammation Signaling |
| Inflammation Signaling | CAUSES | Sarcoidosis |
|---------|-----------|---------|

Reference:
  - [https://go.drugbank.com/drugs/DB00860#mechanism-of-action](https://go.drugbank.com/drugs/DB00860#mechanism-of-action){:target="_blank"}